日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

SC134-deruxtecan, a fucosyl-GM1 targeting ADC for small cell lung cancer therapy.

SC134-deruxtecan,一种靶向岩藻糖基-GM1的抗体药物偶联物,用于治疗小细胞肺癌

Heath Bryony, Kaira Bubacarr G, Thakker Dhruma, Mohammed Omar J, Choudhury Ruhul, Dave Foram, Vaghela Poonam, Dubinina Elena, Parsons Tina, Durrant Lindy, Vankemmelbeke Mireille

Homocitrullination of lysine residues mediated by myeloid-derived suppressor cells in the tumor environment is a target for cancer immunotherapy

肿瘤微环境中髓系来源抑制细胞介导的赖氨酸残基同型瓜氨酸化是癌症免疫治疗的靶点。

Cook, Katherine W; Xue, Wei; Symonds, Peter; Daniels, Ian; Gijon, Mohamed; Boocock, David; Coveney, Clare; Miles, Amanda K; Shah, Sabaria; Atabani, Suha; Choudhury, Ruhul H; Vaghela, Poonam; Weston, Daisy; Metheringham, Rachael L; Brentville, Victoria A; Durrant, Lindy G

Combination vaccine based on citrullinated vimentin and enolase peptides induces potent CD4-mediated anti-tumor responses

基于瓜氨酸化波形蛋白和烯醇化酶肽的联合疫苗可诱导强效的CD4介导的抗肿瘤反应

Brentville, Victoria A; Metheringham, Rachael L; Daniels, Ian; Atabani, Suha; Symonds, Peter; Cook, Katherine W; Vankemmelbeke, Mireille; Choudhury, Ruhul; Vaghela, Poonam; Gijon, Mohamed; Meiners, Ghislaine; Krebber, Willem-Jan; Melief, Cornelis J M; Durrant, Lindy G